Monaghan Medical Corporation and Captis Continue to Partner to Improve Patient Outcomes
June 11, 2024 09:00 ET
|
Monaghan Medical Corporation
Monaghan & Captis announce a 2nd, 3-year contract. The agreement highlights the value of Monaghan, and Captis’ commitment to driving process efficiencies.
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
May 31, 2024 01:05 ET
|
Regeneron Pharmaceuticals, Inc.
Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
May 31, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by...
ENA Respiratory Receives USPTO Notice of Allowance for Key Patent Covering INNA-051, a First-in-Class Antiviral Innate Immunomodulator
May 08, 2024 04:00 ET
|
ENA Respiratory
MELBOURNE, Australia, May 08, 2024 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated...
ENA Respiratory Announces FDA IND Clearance for its Prophylactic Intranasal INNA-051 - a First-in-Class Antiviral Innate Immunomodulator
April 29, 2024 04:00 ET
|
ENA Respiratory
MELBOURNE, Australia, April 29, 2024 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated...
[Latest] Global mHealth Market Size/Share Worth USD 374.6 Billion by 2032 at a 17.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 14, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, March 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “mHealth Market Size, Trends and Insights By Device Type (Cardiac Monitors,...
Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
February 27, 2024 07:00 ET
|
Monaghan Medical Corporation
Monaghan Medical Corporation is proud to have achieved ISO 14001 certification
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
February 23, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in...
Wearable Medical Devices Market Size Worth USD 250.59 Billion in 2032 | Emergen Research
January 11, 2024 08:31 ET
|
Emergen Research
Vancouver, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The global wearable medical devices market size was USD 26.80 Billion in 2022 and is expected to register a rapid revenue CAGR of 25.0% during the...
Monaghan Medical Celebrates Prestigious 2023 AARC Zenith Award Recognition
December 01, 2023 11:47 ET
|
Monaghan Medical Corporation
MONAGHAN MEDICAL CELEBRATES PRESTIGIOUS 2023 AARC ZENITH AWARD RECOGNITION